However, in 20 subfertile patients not taking clomiphene, no cyclical pattern emerged with significantly lower levels of binding sites in the mid-portion of the cycle (P < 0.02) and significantly higher levels in the mid-late luteal phase (P < 0.01), as compared to the normal women. In the mid-portion of the cycle levels were significantly lower in the subfertile patients not taking clomiphene (P < 0.03) as compared to those taking clomiphene. No significant differences were shown between the normal women and those patients taking clomiphene.
Introduction
Although one or more causes can now be identified for many cases of subfertility, there remains a substantial proportion of patients whose primary subfertility is unexplained.' It is possible that some of these women may have subtle defects in the endometrium that do not enable the tissue to respond adequately to hormones secreted by normally functioning ovaries. Indeed, a defect in the ability of cells to take up progesterone into the nucleus2 and a significantly lower level of cytoplasmic progesterone receptors have been described in endometrium from such women.3 Pro- gesterone receptor synthesis is a product of normal oestradiol activity, and it has been shown in rabbit uterine tissue that synthesis of specific binding sites for oxytocin is also stimulated by oestradiol, and repressed by progesterone. 4 Oxytocin is produced and secreted by the posterior pituitary gland and this is involved, through high affinity binding sites in the mammary glands5 and myometrium,6 in the processes of lactation and parturition. Recently, however, it has been shown that the corpus luteum, at least in the ewe, is (Figure 4) although their plasma steroid concentration differed little from those in the normal group. However, when binding site concentrations in the subgroup of patients taking clomiphene were examined, a cyclical pattern not unlike that in the normal group was found ( Figure 5 ).
Clomiphene therapy to subfertile women is derived from significantly increased pregnancy rates in women so treated.'7 Fleming and Coutts'8 found that clomiphene increased follicular development as indicated by elevated pre-ovulatory plasma oestrogen levels, but that this was not 14 28
Day of cycle Figure 4 Oxytocin binding sites in endometrial tissue from subfertile patients not taking clomiphene. followed by increased progesterone concentrations. Figures 1 and 2 
